ALC:NYSE
Alcon AG
75,80Â $
arrow_downward
−0,08%(−0,060) 1 p
75,80Â $
0,00% (0,00)
bedtimePärast tööaega
Suletud: 24. apr, 16:00:08 GMT −4 · USD
search
Kõik sĂ¼mbolid
1 p
5 p
1 kuu
6 kuud
YTD
1 a
5 a
MAX
| SĂ¼mbol | Hind | Muutus | % muutus |
|---|
insights_autoĂœksuse ALC põhistatistika genereerimine…
Ava
75,50Â $
Kõrge
75,94Â $
Madal
75,26Â $
Turu kapit.
29,68Â mld
Keskm. maht
1,42Â mln
Maht
752,28Â tuh
52 näd kõrgeim
99,20Â $
52 näd madalaim
71,55Â $
Beeta
1,03
Käibivad aktsiad
491,20Â mln
Töötajate arv
26Â tuh
Uudised
Erinevatest veebiallikatest
MarketBeat
·
1 tunni eest
Wynn Resorts, Limited (NASDAQ:WYNN) Given Consensus Rating of "Moderate Buy" by Brokerages
MarketBeat
·
1 tunni eest
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages
Yahoo Finance UK
·
1 tunni eest
A once-in-a-decade chance to buy these S&P 500 shares?
Profiil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Teave Ă¼ksuse Alcon AG kohta
TegevjuhtDavid J. Endicott
Töötajad25,9 tuh
Asutatud1945
PeakontoridGenf, Genf, Å veits
Sektor-
Veebisaitalcon.com
AI genereeritud sisu võib sisaldada vigu. Lisateave